Log In
Print
BCIQ
Print
Print this Print this
 

Temodal, Temodar, temozolomide

  Manage Alerts
Collapse Summary General Information
Company Cancer Research Technology Ltd.
DescriptionImidazotetrazine cytotoxic alkylating agent
Molecular Target DNA
Mechanism of ActionBreaks/crosslinks DNA
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBrain cancer
Indication DetailsFirst-line treatment for newly diagnosed glioblastoma multiforme (GBM); Treat glioblastoma multiforme (GBM); Treat high-grade glioma; Treat malignant glioma; Treat newly diagnosed glioblastoma multiforme (GBM) and refractory malignant gliomas, such as anaplastic astrocytoma; Treat newly diagnosed glioblastoma multiforme (GBM) in combination with radiotherapy; Treat refractory anaplastic astrocytoma
Regulatory Designation

Partner

Merck & Co. Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today